RNS Number : 6591M
Marwyn Value Investors Limited
30 April 2024
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO

 

LEI: 213800L5751QTTVEA774

30 April 2024

MARWYN VALUE INVESTORS LIMITED (THE "COMPANY")

SHARE DEALINGS

The Company announces that it has been notified that James Corsellis, partner of Marwyn Investment Management LLP, the manager of the Company, purchased 140,000 Ordinary Shares in the Company at a price of 94.51 pence per share on 30 April 2024.

Also on 30 April 2024, 300,000 Ordinary Shares in the Company were transferred to James Corsellis from his wife, Samantha Corsellis.

Following these transactions, James Corsellis holds 6,168,311 Ordinary Shares, representing approximately 10.91% of the Company's voting rights.

Whilst James Corsellis is not a Person Discharging Managerial Responsibility ("PDMR") within the meaning of UK MAR in relation to the Company, he has voluntarily disclosed the information above to the Company, and the Company is voluntarily disclosing the information above to the market, as if he was a PDMR in relation to the Company.

Company enquiries:

Company Secretary - Aztec Financial Services (Jersey) Limited

Chris Copperwaite / Magdala Mullegadoo

Telephone: 01534 833000

 

Investor Relations

Kam Bansil

Telephone: 020 7039 1901

 

PR Adviser - FGS Global
Rollo Head 07768 994987
Chris Sibbald 07855 955531

 

Corporate Broker - Liberum Capital Limited

Chris Clarke / Owen Matthews

Telephone: 0203 100 2200

 

Shares in the Company are not designed or intended for retail investors. Marwyn Investment Management LLP, the Manager, does not promote shares in the Company to retail investors and they should not be offered to retail investors.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFEVSRIIVIS